Difference between revisions of "Part:BBa K5133006"
Line 9: | Line 9: | ||
==<b>Introduction</b>== | ==<b>Introduction</b>== | ||
− | This composite part is derived from plasmid pJL1 (Addgene: #69496)<sup>[1]</sup>, consisting of four basic parts: T7 promoter (<bbpart>BBa_K5133000</bbpart>), ribosome binding site (RBS, <bbpart>BBa_K5133001</bbpart>), coding sequence of antimicrobial peptide Microcin H47 (<bbpart>BBa_K5133005</bbpart>), and T7 terminator (<bbpart>BBa_K5133003</bbpart>)(<b>Figures 1, 2</b>). The plasmid pJL1 is commonly used for the <i>in vitro</i> protein expression of cell-free protein synthesis (CFPS)<sup>[2]</sup>, and the iGEM-standarized CFPS construction has been constructed and characterized yet (<bbpart>BBa_K5133004</bbpart>). To further expand the application of CFPS systems in iGEM competition, this composite part is designed to demonstrate the feasibility of <i>in vitro</i> antimicrobial peptide (AMP) synthesis by CFPS for extended useful purposes. | + | This composite part is derived from plasmid pJL1 (Addgene: #69496)<sup>[1]</sup>, consisting of four basic parts: T7 promoter (<bbpart>BBa_K5133000</bbpart>), ribosome binding site (RBS, <bbpart>BBa_K5133001</bbpart>), coding sequence of antimicrobial peptide Microcin H47 (<bbpart>BBa_K5133005</bbpart>), and T7 terminator (<bbpart>BBa_K5133003</bbpart>)(<b>Figures 1, 2</b>). The plasmid pJL1 is commonly used for the <i>in vitro</i> protein expression of cell-free protein synthesis (CFPS)<sup>[2]</sup>, and the iGEM-standarized CFPS construction has been constructed and characterized yet in our project (<bbpart>BBa_K5133004</bbpart>). To further expand the application of CFPS systems in iGEM competition, this composite part is designed to demonstrate the feasibility of <i>in vitro</i> antimicrobial peptide (AMP) synthesis by CFPS for extended useful purposes. |
Line 95: | Line 95: | ||
<font size=4><b>Step 1: molecular cloning</b></font> | <font size=4><b>Step 1: molecular cloning</b></font> | ||
− | To construct this part, we first need to acquire the linearized DNA fragments of both vector and inserted fragments. Thus, we amplified vector pSB1C3 and inserted fragments by using PCR. Results of agarose gel electrophoresis showing the desired DNA bands (<b>Figure 4</b>) as pSB1C3 (2070 bp) and inserted fragment ( | + | To construct this part, we first need to acquire the linearized DNA fragments of both vector and inserted fragments. Thus, we amplified vector pSB1C3 and inserted fragments by using PCR. Results of agarose gel electrophoresis showing the desired DNA bands (<b>Figure 4</b>) as pSB1C3 (2070 bp) and inserted fragment (511 bp) used in this construction. Note that the PCR template of inserted fragment was derived from the previously reported research article<sup>[2]</sup>. |
Line 118: | Line 118: | ||
− | <center><b>Figure 4. Agarose gel electrophoresis analysis of PCR products for molecular cloning. The DNA bands indicate one vector pSB1C3 and three inserted fragments. The | + | <center><b>Figure 4. Agarose gel electrophoresis analysis of PCR products for molecular cloning. The DNA bands indicate one vector pSB1C3 and three inserted fragments. The second inserted fragment of BBa_K5133006 (511 bp) is used for the construction of this composite part, while the other two inserted fragments are used for <bbpart>BBa_K5133004</bbpart> and <bbpart>BBa_K5133008</bbpart>, respectively.</b></center> |
Line 140: | Line 140: | ||
</head> | </head> | ||
<body> | <body> | ||
− | <img src="https://static.igem.wiki/teams/5133/bba- | + | <img src="https://static.igem.wiki/teams/5133/bba-k5133006-4.jpg" class="resizable-img5"> |
</body> | </body> | ||
</html> | </html> | ||
Line 154: | Line 154: | ||
<font size=4><b>Step 2: colony PCR</b></font> | <font size=4><b>Step 2: colony PCR</b></font> | ||
− | To verify the constructions, we next performed colony PCR by using the reported protocol<sup>[4]</sup>. For each construction (not only this part, but also <bbpart> | + | To verify the constructions, we next performed colony PCR by using the reported protocol<sup>[4]</sup>. For each construction (not only this part, but also <bbpart>BBa_K5133004</bbpart> and <bbpart>BBa_K5133008</bbpart>), we selected four independent colonies from LB-agar plates and used primer pair VF2/VR to amplify the inserted DNA sequences. After that, we analyzed the DNA products by agarose gel electrophoresis. Results show that three PCR products match the desired DNA sizes of this construction, and the other one was the empty vector of pSB1C3 as false positive (<b>Figure 6</b>). |
Line 179: | Line 179: | ||
− | <center><b>Figure 6. Agarose gel electrophoresis analysis of PCR products for colony PCR. The | + | <center><b>Figure 6. Agarose gel electrophoresis analysis of PCR products for colony PCR. The three DNA products of this construction (BBa_K5133006) match the desired DNA size 782 bp, annotated by green √, while the other one is the empty vector of pSB1C3 as false positive that annotated by red ×.</b></center> |
Revision as of 04:19, 30 July 2024
Microcin H47 generator for CFPS (cell-free protein synthesis)
Group: GEC-China (iGEM 2024, team number: #5133)
Introduction
This composite part is derived from plasmid pJL1 (Addgene: #69496)[1], consisting of four basic parts: T7 promoter (BBa_K5133000), ribosome binding site (RBS, BBa_K5133001), coding sequence of antimicrobial peptide Microcin H47 (BBa_K5133005), and T7 terminator (BBa_K5133003)(Figures 1, 2). The plasmid pJL1 is commonly used for the in vitro protein expression of cell-free protein synthesis (CFPS)[2], and the iGEM-standarized CFPS construction has been constructed and characterized yet in our project (BBa_K5133004). To further expand the application of CFPS systems in iGEM competition, this composite part is designed to demonstrate the feasibility of in vitro antimicrobial peptide (AMP) synthesis by CFPS for extended useful purposes.
Results
For the characterization process of this part, follow five steps showing in Figure 3: (1) molecular cloning; (2) colony PCR; (3) sequencing; (4) plasmid extraction; (5) CFPS reaction.
Step 1: molecular cloning
To construct this part, we first need to acquire the linearized DNA fragments of both vector and inserted fragments. Thus, we amplified vector pSB1C3 and inserted fragments by using PCR. Results of agarose gel electrophoresis showing the desired DNA bands (Figure 4) as pSB1C3 (2070 bp) and inserted fragment (511 bp) used in this construction. Note that the PCR template of inserted fragment was derived from the previously reported research article[2].
When we got the purified DNA products, then we assembled these fragments by using Gibson Assembly strategy[3]. Next, we transformed the reaction to competent E. coli Mach1-T1 cells and spread the transformants onto LB-agar plates containing 34 µg/mL chloramphenicol. As shown in Figure 5, the E. coli transformants could normally grow on LB-agar plates and be used for the following experiments.
Step 2: colony PCR
To verify the constructions, we next performed colony PCR by using the reported protocol[4]. For each construction (not only this part, but also BBa_K5133004 and BBa_K5133008), we selected four independent colonies from LB-agar plates and used primer pair VF2/VR to amplify the inserted DNA sequences. After that, we analyzed the DNA products by agarose gel electrophoresis. Results show that three PCR products match the desired DNA sizes of this construction, and the other one was the empty vector of pSB1C3 as false positive (Figure 6).
Step 3: sequencing
Consequently, we picked the desired PCR products for sequencing. Results of Sanger sequencing show the successful construction of this part (Figure 7), which means that the plasmid could be used for the following experiments.
Step 4: plasmid extract
After we acquired the correct plasmids, we then tried to extract and purify the plasmids for the following CFPS reactions. By using the plasmid extract kit, we gained the purified plasmids and analyzed them by agarose gel electrophoresis. Results in Figure 8 show that the extracted plasmids are clean, consisting of two conformations: linear and supercoiled[5]. To further evaluate the plasmid sizes, we digested the three plasmids by EcoRI (restriction enzyme). After digestion, the three plasmids show the expected linearized comformation and match the desired DNA sizes. These results indicate the successful construction and extraction of this composite part.
Step 5: CFPS reaction
Once the plasmid was successfully constructed and extracted, we performed the CFPS reactions for demonstrating the feasibility of in vitro sfGFP expression (Figure 9).
Before CFPS reaction, we initially established a standard curve for the conversion of "sfGFP (µg/mL)—Fluorescence (a.u.)" (Figure 10).
Subsequently, following the commonly used CFPS protocol[6], we successfully produced sfGFP yielding 1051(±84) µg/mL, which achieved acceptable yield in this research area. Meanwhile, the green color of expressed sfGFP could be clearly observed under the bright field, also the green fluorescence could be detected and imaged by imager (Figure 11).
Conclusion
Taken together, this composite part was successfully constructed and characterized, demonstrating the feasibility of CFPS reaction for the in vitro production of proteins (e.g., sfGFP). Hence, this CFPS system was further utilized for the in vitro production of two antimicrobial peptides in our project, including Microcin H47 (BBa_K5133006) and Microcin M (BBa_K5133008).
DNA sequence (from 5' to 3')
atcccgcgaaattaatacgactcactatagggagaccacaacggtttccctctagaaataattttgtttaactttaagaaggagatatacat atgagcaaaggtgaagaactgtttaccggcgttgtgccgattctggtggaactggatggcgatgtgaacggtcacaaattcagcgtgcgtggtgaaggtgaaggcgatgccacgattggcaaactgacgctgaaattt atctgcaccaccggcaaactgccggtgccgtggccgacgctggtgaccaccctgacctatggcgttcagtgttttagtcgctatccggatcacatgaaacgtcacgatttctttaaatctgcaatgccggaaggctat gtgcaggaacgtacgattagctttaaagatgatggcaaatataaaacgcgcgccgttgtgaaatttgaaggcgataccctggtgaaccgcattgaactgaaaggcacggattttaaagaagatggcaatatcctgggc cataaactggaatacaactttaatagccataatgtttatattacggcggataaacagaaaaatggcatcaaagcgaattttaccgttcgccataacgttgaagatggcagtgtgcagctggcagatcattatcagcag aataccccgattggtgatggtccggtgctgctgccggataatcattatctgagcacgcagaccgttctgtctaaagatccgaacgaaaaaggcacgcgggaccacatggttctgcacgaatatgtgaatgcggcaggt attacgtggagccatccgcagttcgaaaaataagtcgaccggctgctaacaaagcccgaaaggaagctgagttggctgctgccaccgctgagcaataactagcataaccccttggggcctctaaacgggtctt gaggggttttttgctgaaagccaattctga
Red font: T7 promoter (BBa_K5133000)
Green font: RBS (BBa_K5133001)
Blue font: sfGFP (BBa_K5133002)
Purple font: T7 terminator (BBa_K5133003)
References
[1] https://www.addgene.org/69496/
[2] Ba, F. et al. Expanding the toolbox of probiotic Escherichia coli Nissle 1917 for synthetic biology. Biotechnology Journal 19, 2300327 (2024). doi: 10.1002/biot.202300327
[3] Gibson, D.G. et al. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nature Methods 6, 343-345 (2009). doi: 10.1038/nmeth.1318
[4] Ba, F. et al. Rainbow screening: Chromoproteins enable visualized molecular cloning. Biotechnology Journal 19, 2400114 (2024). doi: 10.1002/biot.202400114
[5] Lin, C.H. et al. Quantification bias caused by plasmid DNA conformation in quantitative real-time PCR assay. PLoS One 6, e29101 (2011). doi: 10.1371/journal.pone.0029101
[6] Liu, W.Q. et al. Cell-free protein synthesis enables one-pot cascade biotransformation in an aqueous-organic biphasic system. Biotechnology and Bioengineering 117, 4001-4008 (2020). doi: 10.1002/bit.27541
Sequence and Features
- 10INCOMPATIBLE WITH RFC[10]Illegal XbaI site found at 51
Illegal PstI site found at 166
Illegal PstI site found at 175 - 12INCOMPATIBLE WITH RFC[12]Illegal PstI site found at 166
Illegal PstI site found at 175 - 21COMPATIBLE WITH RFC[21]
- 23INCOMPATIBLE WITH RFC[23]Illegal XbaI site found at 51
Illegal PstI site found at 166
Illegal PstI site found at 175 - 25INCOMPATIBLE WITH RFC[25]Illegal XbaI site found at 51
Illegal PstI site found at 166
Illegal PstI site found at 175 - 1000INCOMPATIBLE WITH RFC[1000]Illegal BsaI.rc site found at 32